BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Business

  Evaxion Announces Business Update and First Quarter 2024 Financial Results

  Evaxion Biotech A/S provides business update and announces first quarter 2024 financial results.

  May 28, 2024

   · 

  9 min read
• Biotech Bay

  New Pilot Study Using the FDA-Cleared Cionic Neural Sleeve Demonstrates Significant Improvements to Gait Impairments for Patients with Multiple Sclerosis

  CIONIC, the neurotech inventor pioneering bionic clothing, today announced data showcasing the impact of the FDA-cleared Cionic Neural Sleeve as assistive technology for individuals experiencing difficulty walking due to multiple sclerosis (MS).

  May 28, 2024

   · 

  3 min read
• Business

  CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK

  CureVac N.V. today announced dosing of the first participant in a Phase 2 study of the multivalent seasonal influenza vaccine candidate developed in collaboration with GSK.

  May 28, 2024

   · 

  6 min read
• BioMidwest

  Integrated DNA Technologies Invests in New U.S. Synthetic Biology Manufacturing Facility

  Global genomics solutions provider Integrated DNA Technologies announced the expansion of its synthetic biology operations with the opening of a new 25,000 square-foot-site in Coralville, IA.

  May 28, 2024

   · 

  4 min read
• Pharm Country

  B. Braun Launches Levetiracetam in Sodium Chloride Injection Portfolio

  B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced today the launch of its new Levetiracetam in Sodium Chloride Injection line of products.

  May 28, 2024

   · 

  2 min read
• Job Trends

  AMGEN TO PRESENT INNOVATIVE RESEARCH FROM ITS ROBUST ONCOLOGY PORTFOLIO AT ASCO 2024

  Amgen (NASDAQ:AMGN) today announced the presentation of new data from its broad oncology portfolio at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting, taking place from May 31-June 4 in Chicago.

  May 28, 2024

   · 

  47 min read
• Business

  Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath’s Board of Directors

  Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, is pleased to announce the appointment of Dr. Bridget Martell to the Company’s Board of Directors effective May 23, 2024.

  May 28, 2024

   · 

  4 min read
• CD Genomics Empowers Researchers to Uncover the Regulatory Secrets of Long Non-Coding RNAs

  As the field of genomics continues to evolve, long non-coding RNAs (lncRNAs) have emerged as a fascinating frontier, offering unprecedented insights into the complex regulatory mechanisms underlying biological processes and disease states

  May 28, 2024

   · 

  3 min read
• Aesthetic Medicine Market Set to Exceed US$ 212.5 Billion in Revenue by 2032

  The global aesthetic medicine market reached a valuation of US$ 75.6 billion in 2023.

  May 28, 2024

   · 

  6 min read
• Mithra postpones its annual general meeting

  Mithra, a company dedicated to women’s health, announces that in the context of the monetization process and the uncertainties related thereto, Mithra postpones its Annual General Shareholders’ Meeting, previously planned for 30 May 2024, to a later date to be determined.

  May 28, 2024

   · 

  3 min read